Geburtshilfe und Frauenheilkunde, Inhaltsverzeichnis Geburtshilfe Frauenheilkd 2004; 64(2): R17-R32DOI: 10.1055/s-2004-820856 GebFra-Refresher Georg Thieme Verlag Stuttgart · New York Endogene Steuerung der Ovarialfunktion - Teil 2 B. Sonntag1 , L. Kiesel1 1Münster Artikel empfehlen Abstract Artikel einzeln kaufen Volltext Referenzen Literatur 1 Leidenberger F A. Klinische Endokrinologie für Frauenärzte. Heidelberg; Springer 1997 2 Eijkemans M J, Habbema J D, Fauser B C. Characteristics of the best prognostic evidence: an example on prediction of outcome after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrhoeic infertility. Semin Reprod Med. 2003; 21 39-48 3 Smith T P, Suliman A M, Fahie-Wilson M N, McKenna T J. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab. 2002; 87 5410-5415 4 Geisthoevel F. Funktioneller Hyperandrogenismus (sog. „Syndrom polyzystischer Ovarien“). Gynäkologe. 2002; 35 48-63 5 Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles?. Hum Reprod. 2003; 18 598-603 6 Goodarzi M O, Korenman S G. The importance of insulin resistance in polycystic ovary syndrome. Fertil Steril. 2003; 80 255-258 7 Palmert M R, Gordon C M, Kartashov A I, Legro R S, Emans S J, Dunaif A. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87 1017-1023 8 Carmina E, Lobo R A. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab. 1999; 84 1897-1899 9 Laml T, Preyer O, Umek W, Hengstschlager M, Hanzal H. Genetic disorders in premature ovarian failure. Hum Reprod Update. 2002; 8 483-491 10 Speiser P W, White P C. Congenital adrenal hyperplasia. N Engl J Med. 2003; 349 776-788 11 Vasseur C, Rodien P, Beau I, Desroches A, Gerard C, de Poncheville L, Chaplot S, Savagner F, Croue A, Mathieu E, Lahlou N, Descamps P, Misrahi M. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med. 2003; 349 753-759 12 Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med. 2001; 52 401-419 13 Lenton E A, Sexton L, Lee S, Cooke I D. Progressive changes in LH and FSH and LH: FSH ratio in women throughout reproductive life. Maturitas. 1988; 10 35-43 14 Yong P Y, Baird D T, Thong K J, McNeilly A S, Anderson R A. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum Reprod. 2003; 18 35-44 15 Scheffer G J, Broekmans F J, Looman C W, Blankenstein M, Fauser B C, teJong F H, teVelde E R. The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod. 2003; 18 700-706 16 Navot D, Rosenwaks Z, Margalioth E J. Prognostic assessment of female fecundity. Lancet. 1987; 2 645-647 17 Ravhon A, Lavery S, Michael S, Donaldson M, Margara R, Trew G, Winston R. Dynamic assays of inhibin B and oestradiol following buserelin acetate administration as predictors of ovarian response in IVF. Hum Reprod. 2000; 15 2297-2301 18 Winslow K L, Toner J P, Brzyski R G, Oehninger S C, Acosta A A, Muasher S J. The gonadotropin-releasing hormone agonist stimulation test - a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril. 1991; 56 711-717 19 Elting M W, Kwee J, Schats R, Rekers-Mombarg L T, Schoemaker J. The rise of estradiol and inhibin B after acute stimulation with follicle-stimulating hormone predict the follicle cohort size in women with polycystic ovary syndrome, regularly menstruating women with polycystic ovaries, and regularly menstruating women with normal ovaries. J Clin Endocrinol Metab. 2001; 86 1589-1595 20 Fanchin R, de Ziegler D, Olivennes F, Taieb J, Dzik A, Frydman R. Exogenous follicle stimulating hormone ovarian reserve test (EFORT): a simple and reliable screening test for detecting ‘poor responders' in in-vitro fertilization. Hum Reprod. 1994; 9 1607-1611 21 van Rooij I A, Broekmans F J, te Velde E R, Fauser B C, Bancsi L F, de Jong F H, Themmen A P. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002; 17 3065-3071
